Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression

被引:0
|
作者
Chuan Tian
Mubalake Abudoureyimu
Xinrong Lin
Xiaoyuan Chu
Rui Wang
机构
[1] Affiliated Jinling Hospital,Department of Medical Oncology
[2] Medical School of Nanjing University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Linc-ROR have been well-demonstrated to play important roles in cancer progression and angiogenesis. However, the underlying oncogenic mechanism of Linc-ROR in hepatocellular carcinoma is poorly understood. In this study, we demonstrate that Linc-ROR plays an oncogenic role in part through its positive regulation of DEPDC1 expression. Mechanistically, Linc-ROR acts as competing endogenous RNA to stabilize DEPDC1 mRNA and regulates DEPDC1 mRNA stability by binding HNRNPK. Thus, these findings suggest that function of Linc-ROR-mediated DEPDC1 could predispose hepatocellular carcinoma patients to progression and angiogenesis, and may serve as a potential target for anticancer therapies.
引用
收藏
相关论文
共 50 条
  • [1] Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression
    Tian, Chuan
    Abudoureyimu, Mubalake
    Lin, Xinrong
    Chu, Xiaoyuan
    Wang, Rui
    CELL DEATH & DISEASE, 2021, 12 (11)
  • [2] Correction to: Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression
    Chuan Tian
    Mubalake Abudoureyimu
    Xinrong Lin
    Xiaoyuan Chu
    Rui Wang
    Cell Death & Disease, 13
  • [3] Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression (vol 12, 1047, 2021)
    Tian, Chuan
    Abudoureyimu, Mubalake
    Lin, Xinrong
    Chu, Xiaoyuan
    Wang, Rui
    CELL DEATH & DISEASE, 2021, 13 (01)
  • [4] YY1-mediated DUXAP8 facilitates HCC progression via modulating DEPDC1 expression
    Yi Cui
    Yong Sun
    Na Liang
    Chuan Tian
    Clinical and Experimental Medicine, 25 (1)
  • [5] linc-ROR facilitates hepatocellular carcinoma resistance to doxorubicin by regulating TWIST1-mediated epithelial-mesenchymal transition
    Zhang, Yuanbiao
    Wu, Weiding
    Sun, Qiang
    Ye, Longyun
    Zhou, Dongkai
    Wang, Weilin
    MOLECULAR MEDICINE REPORTS, 2021, 23 (05)
  • [6] FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma
    Zhi, Yingru
    Abudoureyimu, Mubalake
    Zhou, Hao
    Wang, Ting
    Feng, Bing
    Wang, Rui
    Chu, Xiaoyuan
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 16 : 576 - 588
  • [7] DEPDC1 is required for cell cycle progression and motility in nasopharyngeal carcinoma
    Feng, Xuefei
    Zhang, Chundong
    Zhu, Ling
    Zhang, Lian
    Li, Hongxia
    He, Longxia
    Mi, Yan
    Wang, Yitao
    Zhu, Jiang
    Bu, Youquan
    ONCOTARGET, 2017, 8 (38) : 63605 - 63619
  • [8] Prognostic Value of DEPDC1 Expression in Tumor and Non-tumor Tissue of Patients With Hepatocellular Carcinoma
    Amisaki, Masataka
    Yagyu, Takuki
    Uchinaka, Ei
    Morimoto, Masaki
    Hanaki, Takehiko
    Watanabe, Joji
    Tokuyasu, Naruo
    Sakamoto, Teruhisa
    Honjo, Soichiro
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2019, 39 (08) : 4423 - 4430
  • [9] Linc-ROR promotes esophageal squamous cell carcinoma progression through the derepression of SOX9
    Lianghai Wang
    Xiaodan Yu
    Zhiyu Zhang
    Lijuan Pang
    Jiang Xu
    Jinfang Jiang
    Weihua Liang
    Yuhang Chai
    Jun Hou
    Feng Li
    Journal of Experimental & Clinical Cancer Research, 36
  • [10] Linc-ROR promotes esophageal squamous cell carcinoma progression through the derepression of SOX9
    Wang, Lianghai
    Yu, Xiaodan
    Zhang, Zhiyu
    Pang, Lijuan
    Xu, Jiang
    Jiang, Jinfang
    Liang, Weihua
    Chai, Yuhang
    Hou, Jun
    Li, Feng
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36